$35 insulin price caps, lower list prices bring relief | Sha

Sanofi is joining the nation’s two other major insulin manufacturers in offering either price caps or savings programs that lower the cost of the drugs to $35 for many patients.

Related Keywords

United States , Americans , American , Spencer Perlman , Eli Lilly , American Diabetes Association , Health Policy Center , Lilly Insulin Value Program , Novo Nordisk , More Americans , American Diabetes , Inflation Reduction Act , Tim Lash , West Health Policy Center , Rescue Plan Act , Veda Partners , ,